RECK and hepatocellular carcinoma: Their group identified two SNPs of interest in the development of HCC; individuals with the RECK promoter rs10814325 polymorphism saw increased risk of developing HCC compared to wild-type carriers, while HCC patients carrying the rs11788747 had higher risk of developing distant metastasis than wild-type carriers (36).